Get the Stockscreener App
20.04
1.42%
0.28
After Hours:
19.17
-0.87
-4.34%
Elanco Animal Health Inc stock is traded at $20.04, with a volume of 4.52M.
It is up +1.42% in the last 24 hours and up +8.15% over the past month.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See More
Previous Close:
$19.76
Open:
$20.05
24h Volume:
4.52M
Relative Volume:
0.65
Market Cap:
$9.96B
Revenue:
$4.45B
Net Income/Loss:
$205.00M
P/E Ratio:
50.10
EPS:
0.4
Net Cash Flow:
$372.00M
1W Performance:
-3.00%
1M Performance:
+8.15%
6M Performance:
+132.48%
1Y Performance:
+39.46%
1-Day Range:
$19.96
$20.38
1-Week Range:
$19.45
$21.76
52-Week Range:
$8.02
$21.76
Elanco Animal Health Inc Stock (ELAN) Company Profile
Name
Elanco Animal Health Inc
Sector
Phone
877-352-6261
Address
2500 INNOVATION WAY, GREENFIELD
Compare ELAN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
20.04 | 9.82B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
142.26 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.08 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.02 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.06 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-17-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-26-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-09-24 | Initiated | UBS | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Market Perform |
| Sep-19-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-19-23 | Initiated | Jefferies | Buy |
| Dec-15-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Apr-20-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-18-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-16-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Sell |
| Jul-12-22 | Initiated | Piper Sandler | Neutral |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Oct-28-21 | Downgrade | Stifel | Buy → Hold |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jun-15-21 | Upgrade | Cleveland Research | Underperform → Neutral |
| May-11-21 | Upgrade | Barclays | Underweight → Equal Weight |
| May-11-21 | Upgrade | Gabelli & Co | Hold → Buy |
| Apr-15-21 | Initiated | Stifel | Buy |
| Mar-22-21 | Downgrade | Gabelli & Co | Buy → Hold |
| Feb-26-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-09-20 | Downgrade | Argus | Buy → Hold |
| Nov-09-20 | Downgrade | Barclays | Overweight → Underweight |
| Aug-20-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-13-20 | Resumed | Credit Suisse | Neutral |
| Aug-04-20 | Resumed | Goldman | Buy |
| Jul-27-20 | Downgrade | Cleveland Research | Neutral → Underperform |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Dec-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-07-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-19 | Initiated | Barclays | Overweight |
| Aug-26-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-15-19 | Upgrade | UBS | Sell → Neutral |
| May-23-19 | Initiated | Guggenheim | Neutral |
| Mar-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-13-19 | Resumed | Morgan Stanley | Equal-Weight |
| Feb-12-19 | Initiated | William Blair | Mkt Perform |
| Jan-23-19 | Initiated | UBS | Sell |
| Jan-15-19 | Initiated | Argus | Buy |
| Oct-15-18 | Initiated | Morgan Stanley | Equal-Weight |
View All
Elanco Animal Health Inc Stock (ELAN) Latest News
Detecting support and resistance levels for Elanco Animal Health IncorporatedQuarterly Portfolio Summary & Target Return Focused Picks - newser.com
Will breakout in Elanco Animal Health Incorporated lead to full recoveryWeekly Trade Summary & Real-Time Buy Signal Notifications - newser.com
Elanco Animal Health Incorporated stock trend outlook and recovery pathIndex Update & Community Shared Stock Ideas - newser.com
Elanco Animal Health (ELAN) Stock Analysis: Growth Potential And Market Dynamics - DirectorsTalk Interviews
Animal Healthcare Market Size, Trends Analysis 2032 by Key - openPR.com
Rep. Val T. Hoyle Sells Elanco Animal Health Incorporated (NYSE:ELAN) Shares - MarketBeat
Callan Family Office LLC Purchases 117,174 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Tick level data insight on Elanco Animal Health Incorporated volatilityLong Setup & Accurate Entry/Exit Alerts - newser.com
Elanco Animal Health Incorporated $ELAN Shares Sold by Truist Financial Corp - MarketBeat
Multi asset correlation models including Elanco Animal Health IncorporatedPortfolio Growth Summary & Accurate Buy Signal Notifications - newser.com
Elanco Animal Health's (ELAN) Hold (C-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Pet Owner Keeps State, But Not Fed., Elanco Tick Meds Suit - Law360
Combining machine learning predictions for Elanco Animal Health IncorporatedJuly 2025 Decliners & Consistent Growth Equity Picks - newser.com
U.S. Animal Disinfectant Market 2025-2032: Industry Outlook, - openPR.com
Combining price and volume data for Elanco Animal Health IncorporatedJuly 2025 Sector Moves & Low Risk High Win Rate Stock Picks - newser.com
What catalysts could drive Elanco Animal Health Incorporated stock higherWeekly Market Report & Weekly High Momentum Picks - newser.com
Elanco Escapes Some, but Not All, Claims in Animal Products Suit - Bloomberg Law News
Elanco Animal Health Hits New 52-Week High at $21.76 - Markets Mojo
Judge Limits Lawsuit Alleging Elanco Monopolized Pet Medication Market - PYMNTS.com
Hausfeld Expands Counsel Team with Former Government Enforcement Leaders - PYMNTS.com
Advantix-maker Elanco must face some price-fixing claims over flea, tick products - Reuters
Elanco Animal Health Incorporated (ELAN) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Acadia Healthcare names Todd Young as CFO amid activist investor pressure - Reuters
Elanco Animal Health (ELAN): Reviewing Valuation After Analyst Upgrade and S&P MidCap 400 Inclusion - Yahoo Finance
Country Club Bank Has $2.37 Million Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health upgraded to ’BB’ on lower leverage - Investing.com
Why Elanco (ELAN) Stock Is Trading Up Today - TradingView
Elanco Animal Health stock hits 52-week high at 21.18 USD - Investing.com Canada
Why Elanco Animal Health (ELAN) Is Up 5.4% After FDA Removes Major Zenrelia Safety Warning - Yahoo Finance
Elanco Animal Health (NYSE:ELAN) Rating Increased to Overweight at JPMorgan Chase & Co. - MarketBeat
JPMorgan Upgrades Elanco Animal Health to Overweight From Neutral, Adjusts Price Target to $24 From $18 - MarketScreener
This Netflix Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday - Benzinga
JP Morgan Upgrades Elanco Animal Health (ELAN) with Raised Price Target | ELAN Stock News - GuruFocus
Elanco Animal Health (NYSE:ELAN) Shares Gap Down to $20.56 - 富途牛牛
Elanco Animal Health (ELAN): Assessing Valuation After Recent Share Price Momentum - simplywall.st
Visual analytics tools that track Elanco Animal Health Incorporated performanceJuly 2025 Earnings & Safe Capital Growth Tips - newser.com
Can Elanco Animal Health Incorporated rally from current levelsQuarterly Market Summary & AI Enhanced Execution Alerts - newser.com
Using economic indicators to assess Elanco Animal Health Incorporated potentialJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - newser.com
Elanco Animal Health Hits New 52-Week High of $20.91 - Markets Mojo
Elanco Animal Health (ELAN) Is Up 8.2% After FDA Strengthens Zenrelia Safety Labeling – Has the Bull Case Changed? - simplywall.st
Q&A with Elanco’s Jeff Simmons on blockbusters, challenges and growing up on a vineyard - Indianapolis Business Journal
After 5 years, Elanco moves in to west side Indy headquarters. Take a look inside - IndyStar
Is this a good reentry point in Elanco Animal Health IncorporatedInsider Buying & AI Based Buy/Sell Signal Reports - newser.com
Can Elanco Animal Health Incorporated stock attract ESG investmentsTrade Risk Assessment & Accurate Technical Buy Alerts - newser.com
Is Elanco Animal Health Incorporated stock a smart buy before Fed meetingTrade Risk Summary & Community Trade Idea Sharing - newser.com
How to build a dashboard for Elanco Animal Health Incorporated stockPortfolio Performance Report & High Accuracy Buy Signal Tips - newser.com
Sentiment analysis tools applied to Elanco Animal Health Incorporated2025 Retail Activity & Long-Term Growth Stock Strategies - newser.com
ASR Vermogensbeheer N.V. Trims Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health (NYSE:ELAN) Reaches New 1-Year HighHere's What Happened - MarketBeat
Elanco Opens New $200 Million Global Headquarters in Downtown Indianapolis - Hoosier Ag Today
Elanco Animal Health Inc Stock (ELAN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):